Sort   by:  
 Page size 
UnknownOutcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial.
Not available
S-EPMC5815562 | biostudies-literature
UnknownPhase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.
Not available
S-EPMC5791843 | biostudies-literature
UnknownDementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
Not available
S-EPMC8634124 | biostudies-literature
UnknownPosterior cortical atrophy phenotypic heterogeneity revealed by decoding 18F-FDG-PET.
Not available
S-EPMC8600283 | biostudies-literature
UnknownUncovering the distinct macro-scale anatomy of dysexecutive and behavioural degenerative diseases.
Not available
S-EPMC10994526 | biostudies-literature
UnknownStudy of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration.
Not available
S-EPMC5269612 | biostudies-literature
UnknownPatient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
Not available
S-EPMC10653042 | biostudies-literature
UnknownExtensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers.
Not available
S-EPMC6781370 | biostudies-literature
UnknownProgressive dysexecutive syndrome due to Alzheimer's disease: a description of 55 cases and comparison to other phenotypes.
Not available
S-EPMC7325839 | biostudies-literature
UnknownSpleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659).
Not available
S-EPMC9882996 | biostudies-literature
Sort   by:  
 Page size